Results 221 to 230 of about 8,086 (233)

THE FC‐RECEPTOR NEONATAL (FCRN) TRAFFICS THROUGH THE COMMON ENDOSOME IN MUCOSAL EPITHELIAL CELLS

Journal of Pediatric Gastroenterology and Nutrition, 2005
Elizabeth H Yen, M Kothe, J Wagner, W I Lencer   +3 more
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Hope S Rugo, Gabriel N Hortobagyi   +2 more
exaly  

Gastroenteropancreatic Neuroendocrine Tumors

Ca-A Cancer Journal for Clinicians, 2018
Mauro Cives
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors

Ca-A Cancer Journal for Clinicians, 2011
Kiran K Turaga
exaly  

Advances in Prostate Cancer Chemotherapy: A New Era Begins

Ca-A Cancer Journal for Clinicians, 2005
Kenneth J Pienta, David C Smith
exaly  

Breast cancer statistics, 2013

Ca-A Cancer Journal for Clinicians, 2014
exaly  

Hypogammaglobulinemia Following Use of An Anti-neonatal Fc Receptor (FcRn) Monoclonal Antibody, Efgartigimod.

Journal of Allergy and Clinical Immunology
Nancy Yang, Baijun Zhou, Joseph Hong, Sara Barmettler   +3 more
openaire   +1 more source

Targeting Apoptosis Pathways in Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2005
exaly